Ximelagatran for secondary prevention of venous thromboembolism.
Böger
Carsten
C
Schroll
Stephan
S
Holmer
Stephan
S
D000925:Anticoagulants / Q000627:therapeutic use*; D001384:Azetidines / Q000627:therapeutic use*; D001596:Benzylamines; D006801:Humans; D012107:Research Design; D012306:Risk; D055502:Secondary Prevention; D013923:Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; C426686:ximelagatran